Funding for this research was provided by:
Japan Agency for Medical Research and Development
Core Research for Evolutional Science and Technology
Received: 1 August 2016
Accepted: 6 September 2016
First Online: 3 October 2016
Conflict of interest
: M.S.H.K. is a cofounder of Elixirgen, LLC, which promotes clinical application of human Zscan4.